The life-sciences and electronics company said its earnings before interest, taxes, depreciation and amortization before one-time items--the company's preferred profitability metric--rose 3.3% to 6.07 ...

The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that ...

Petco Love, a national nonprofit leading lifesaving pet initiatives, proudly announces March as National Pet Vaccination Month. This des ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

Seven & i Holdings named director Stephen Dacus as the new chief executive and said it aims to list its North American convenience-store unit by the end of 2026. Iron-ore giant Rio Tinto will invest ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in ...

In the corporate sector, Lufthansa (ETR: LHAG) reported a decline in its full-year operating profit for 2024, with the ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for shares of Mersana Therapeutics in a ...